KBI plans $150M fa­cil­i­ty in Re­search Tri­an­gle Park with mys­tery co-in­vestor

A month af­ter un­veil­ing plans for a new man­u­fac­tur­ing fa­cil­i­ty in Gene­va, KBI Bio­phar­ma has al­ready pegged the lo­ca­tion for its next site: a $150 mil­lion fa­cil­i­ty in Re­search Tri­an­gle Park, North Car­oli­na.

The 140,000-square-foot fa­cil­i­ty will be ful­ly op­er­a­tional by Q1 2022, and the con­tract ser­vices com­pa­ny says it will be home to more than 200 op­er­a­tions and qual­i­ty as­sur­ance staffers. A mys­tery part­ner is chip­ping in on the fa­cil­i­ty to man­u­fac­ture its pro­tein ther­a­pies, though KBI is keep­ing mum about who.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER